Bioventus Net Debt from 2010 to 2026

BVS Stock

USD 8.27 0.17 2.10%

Bioventus Net Debt yearly trend continues to be comparatively stable with very little volatility. Net Debt will likely drop to about 255.1 M in 2026. Net Debt is the total debt of Bioventus minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2016-03-31

Previous Quarter

308.3 M

Current Value

280.4 M

Quarterly Volatility

123.4 M

Yuan Drop

Covid

Interest Hikes

Check Bioventus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bioventus' main balance sheet or income statement drivers, such as Depreciation And Amortization of 40.1 M, Interest Expense of 46.8 M or Total Revenue of 394.6 M, as well as many indicators such as Price To Sales Ratio of 1.31, Dividend Yield of 5.0E-4 or PTB Ratio of 4.93. Bioventus financial statements analysis is a perfect complement when working with Bioventus Valuation or Volatility modules.

Build AI portfolio with Bioventus Stock

Check out the analysis of Bioventus Correlation against competitors.

For more information on how to buy Bioventus Stock please use our How to Invest in Bioventus guide.

The evolution of Net Debt for Bioventus provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Bioventus compares to historical norms and industry peers.

Latest Bioventus' Net Debt Growth Pattern

Below is the plot of the Net Debt of Bioventus over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Bioventus' Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bioventus' overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

Bioventus Net Debt Regression Statistics

	Arithmetic Mean	212,091,083
	Geometric Mean	195,725,853
	Coefficient Of Variation	42.95
	Mean Deviation	79,327,401
	Median	155,202,000
	Standard Deviation	91,095,416
	Sample Variance	8298.4T
	Range	286.3M
	R-Value	0.69
	Mean Square Error	4594.8T
	R-Squared	0.48
	Significance	0
	Slope	12,510,036
	Total Sum of Squares	132774T

Bioventus Net Debt History

	2026	255.1 M
	2025	338.2 M
	2024	294 M
	2023	357.9 M
	2022	387.9 M
	2021	313.7 M
	2020	101.5 M

Other Fundumenentals of Bioventus

Net Debt To E B I T D A

Bioventus Net Debt component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Net Tangible Assets	Property Plant Equipment	Long Term Debt	Net Invested Capital	Long Term Investments	Short Long Term Debt	Capital Stock	Net Working Capital	Short Term Investments	Capital Surpluse	Deferred Long Term Liab
Total Assets		0.8	0.23	0.88	-0.28	0.86	0.82	-0.01	0.97	0.78	0.63	0.96	-0.67	-0.58	0.71	0.9	0.98	0.39	0.81	-0.86	-0.71	-0.21	-0.21	-0.21
Total Stockholder Equity	0.8		0.45	0.55	0.26	0.43	0.4	0.52	0.65	0.35	0.3	0.84	-0.53	-0.54	0.38	0.56	0.84	0.64	0.34	-0.53	-0.42	-0.08	-0.08	-0.08
Current Deferred Revenue	0.23	0.45		-0.1	0.29	-0.14	0.21	0.74	0.12	0.24	-0.07	0.16	0.31	0.36	0.21	-0.03	0.26	0.89	-0.05	0.0	0.25	0.2	0.2	0.2
Net Debt	0.88	0.55	-0.1		-0.56	0.95	0.85	-0.3	0.92	0.8	0.76	0.91	-0.81	-0.73	0.71	0.98	0.88	0.07	0.89	-0.94	-0.61	-0.28	-0.28	-0.28
Retained Earnings	-0.28	0.26	0.29	-0.56		-0.63	-0.7	0.77	-0.46	-0.72	-0.55	-0.24	0.35	0.16	-0.55	-0.6	-0.28	0.3	-0.74	0.66	0.24	0.51	0.51	0.51
Accounts Payable	0.86	0.43	-0.14	0.95	-0.63		0.89	-0.45	0.94	0.84	0.75	0.82	-0.68	-0.57	0.71	0.94	0.81	-0.02	0.93	-0.89	-0.76	-0.27	-0.27	-0.27
Net Receivables	0.82	0.4	0.21	0.85	-0.7	0.89		-0.29	0.89	0.99	0.66	0.75	-0.51	-0.31	0.85	0.9	0.81	0.27	0.94	-0.9	-0.5	-0.34	-0.34	-0.34
Good Will	-0.01	0.52	0.74	-0.3	0.77	-0.45	-0.29		-0.21	-0.29	-0.37	0.06	0.22	0.1	-0.22	-0.3	0.06	0.72	-0.48	0.3	0.41	0.39	0.39	0.39
Total Liab	0.97	0.65	0.12	0.92	-0.46	0.94	0.89	-0.21		0.86	0.69	0.91	-0.65	-0.52	0.77	0.94	0.93	0.25	0.9	-0.89	-0.76	-0.25	-0.25	-0.25
Total Current Assets	0.78	0.35	0.24	0.8	-0.72	0.84	0.99	-0.29	0.86		0.63	0.7	-0.48	-0.25	0.87	0.87	0.77	0.3	0.94	-0.88	-0.44	-0.34	-0.34	-0.34
Short Term Debt	0.63	0.3	-0.07	0.76	-0.55	0.75	0.66	-0.37	0.69	0.63		0.64	-0.66	-0.5	0.67	0.71	0.58	0.01	0.75	-0.7	-0.5	-0.28	-0.28	-0.28
Intangible Assets	0.96	0.84	0.16	0.91	-0.24	0.82	0.75	0.06	0.91	0.7	0.64		-0.79	-0.74	0.66	0.91	0.98	0.37	0.75	-0.87	-0.59	-0.21	-0.21	-0.21
Common Stock	-0.67	-0.53	0.31	-0.81	0.35	-0.68	-0.51	0.22	-0.65	-0.48	-0.66	-0.79		0.92	-0.58	-0.79	-0.71	-0.04	-0.67	0.8	0.45	0.37	0.37	0.37
Net Tangible Assets	-0.58	-0.54	0.36	-0.73	0.16	-0.57	-0.31	0.1	-0.52	-0.25	-0.5	-0.74	0.92		-0.31	-0.66	-0.63	0.07	-0.46	0.65	0.4	0.13	0.13	0.13
Property Plant Equipment	0.71	0.38	0.21	0.71	-0.55	0.71	0.85	-0.22	0.77	0.87	0.67	0.66	-0.58	-0.31		0.77	0.7	0.38	0.88	-0.79	-0.36	-0.26	-0.26	-0.26
Long Term Debt	0.9	0.56	-0.03	0.98	-0.6	0.94	0.9	-0.3	0.94	0.87	0.71	0.91	-0.79	-0.66	0.77		0.91	0.15	0.93	-0.97	-0.6	-0.36	-0.36	-0.36
Net Invested Capital	0.98	0.84	0.26	0.88	-0.28	0.81	0.81	0.06	0.93	0.77	0.58	0.98	-0.71	-0.63	0.7	0.91		0.44	0.78	-0.89	-0.58	-0.29	-0.29	-0.29
Long Term Investments	0.39	0.64	0.89	0.07	0.3	-0.02	0.27	0.72	0.25	0.3	0.01	0.37	-0.04	0.07	0.38	0.15	0.44		0.11	-0.19	0.15	0.12	0.12	0.12
Short Long Term Debt	0.81	0.34	-0.05	0.89	-0.74	0.93	0.94	-0.48	0.9	0.94	0.75	0.75	-0.67	-0.46	0.88	0.93	0.78	0.11		-0.92	-0.61	-0.37	-0.37	-0.37
Capital Stock	-0.86	-0.53	0.0	-0.94	0.66	-0.89	-0.9	0.3	-0.89	-0.88	-0.7	-0.87	0.8	0.65	-0.79	-0.97	-0.89	-0.19	-0.92		0.52	0.47	0.47	0.47
Net Working Capital	-0.71	-0.42	0.25	-0.61	0.24	-0.76	-0.5	0.41	-0.76	-0.44	-0.5	-0.59	0.45	0.4	-0.36	-0.6	-0.58	0.15	-0.61	0.52		0.22	0.22	0.22
Short Term Investments	-0.21	-0.08	0.2	-0.28	0.51	-0.27	-0.34	0.39	-0.25	-0.34	-0.28	-0.21	0.37	0.13	-0.26	-0.36	-0.29	0.12	-0.37	0.47	0.22		1.0	1.0
Capital Surpluse	-0.21	-0.08	0.2	-0.28	0.51	-0.27	-0.34	0.39	-0.25	-0.34	-0.28	-0.21	0.37	0.13	-0.26	-0.36	-0.29	0.12	-0.37	0.47	0.22	1.0		1.0
Deferred Long Term Liab	-0.21	-0.08	0.2	-0.28	0.51	-0.27	-0.34	0.39	-0.25	-0.34	-0.28	-0.21	0.37	0.13	-0.26	-0.36	-0.29	0.12	-0.37	0.47	0.22	1.0	1.0

Click cells to compare fundamentals

About Bioventus Financial Statements

Bioventus shareholders use historical fundamental indicators, such as Net Debt, to determine how well the company is positioned to perform in the future. Although Bioventus investors may analyze each financial statement separately, they are all interrelated. The changes in Bioventus' assets and liabilities, for example, are also reflected in the revenues and expenses on on Bioventus' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Net Debt	338.2 M	255.1 M
Net Debt To EBITDA	8.62	9.05

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Bioventus Stock Analysis

When running Bioventus' price analysis, check to measure Bioventus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventus is operating at the current time. Most of Bioventus' value examination focuses on studying past and present price action to predict the probability of Bioventus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventus' price. Additionally, you may evaluate how the addition of Bioventus to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Bioventus Net Debt from 2010 to 2026

Latest Bioventus' Net Debt Growth Pattern

Bioventus Net Debt Regression Statistics

Bioventus Net Debt History

Other Fundumenentals of Bioventus

Bioventus Net Debt component correlations

About Bioventus Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Bioventus Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY